Bone Biologics Faces Delisting Concerns
Ticker: BBLGW · Form: 8-K · Filed: Apr 11, 2025 · CIK: 1419554
| Field | Detail |
|---|---|
| Company | Bone Biologics Corp (BBLGW) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: BBLG
TL;DR
BBLG might get delisted, filing shows.
AI Summary
Bone Biologics Corporation filed an 8-K on April 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The earliest event reported was April 7, 2025. The company is incorporated in Delaware and its principal executive offices are located in Burlington, MA.
Why It Matters
This filing indicates potential issues with Bone Biologics Corporation's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Bone Biologics Corporation (company) — Registrant
- April 7, 2025 (date) — Earliest event reported
- April 11, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Burlington, MA (location) — Principal executive offices
FAQ
What is the specific reason for Bone Biologics Corporation's potential delisting?
The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard not met.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 7, 2025.
What is the filing date of this 8-K report?
The filing was made on April 11, 2025.
Where are Bone Biologics Corporation's principal executive offices located?
The principal executive offices are located at 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803.
What is the SEC file number for Bone Biologics Corporation?
The SEC file number for Bone Biologics Corporation is 001-40899.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 regarding Bone Biologics Corp (BBLGW).